Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000890453 | SCV001034199 | benign | not provided | 2018-08-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028396 | SCV003870036 | uncertain significance | not specified | 2023-02-16 | criteria provided, single submitter | clinical testing | The c.2868G>A (p.M956I) alteration is located in exon 24 (coding exon 24) of the MYO16 gene. This alteration results from a G to A substitution at nucleotide position 2868, causing the methionine (M) at amino acid position 956 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000890453 | SCV005236108 | benign | not provided | criteria provided, single submitter | not provided |